Cynthia Collins
CIK 1405692 · CEO · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$854.6K
Companies
8
Total Filings
81
Lifetime Open-Market Net
-$299.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MXCT | Director | 111,310 | $1.24 | $138.0K | $0 | 3 | 2026-06-22 |
| CDXS | Director | 112,157 | $1.48 | $166.0K | $0 | 3 | 2026-06-18 |
| CERT | Director | 51,846 | $8.13 | $421.5K | $0 | 7 | 2026-05-15 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $0 | 5 | 2025-01-08 |
| DermTech, Inc. (DMTK) Delisted | Director | 104,835 | $0.09 | $9.9K | $0 | 6 | 2023-06-05 |
| EDIT | CEO | 43,760 | $2.95 | $129.1K | -$290.7K | 9 | 2021-02-10 |
| GENVEC INC (GNVC) Delisted | President & CEO | — | — | — | $0 | 2 | 2013-01-24 |
| BECKMAN COULTER INC (BEC) Delisted | Group Vice President | 10,665 | — | — | -$8.7K | 45 | 2011-06-28 |
Recent Filings · Page 4 of 9
81 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-14 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2019-02-04 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2018-12-10 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2013-01-24 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-05-25 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-07-05 | — | Mixed | −10,665 | -$1.26M | |
| 2011-06-28 | BECKMAN COULTER INC (BEC) Delisted | U | −8,552 | -$714.1K | EDGAR |
| 2011-03-07 | BECKMAN COULTER INC (BEC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-11 | BECKMAN COULTER INC (BEC) Delisted | Tax (F) | −283 | -$20.9K | EDGAR |
| 2011-01-10 | BECKMAN COULTER INC (BEC) Delisted | Mixed | +1,727 | -$14.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.